Sotagliflozin

View Clinical trials for Sotagliflozin Get Sotagliflozin Patent Info for Free

Sotagliflozin is an investigational new oral dual inhibitor of sodium-glucose cotransporters 1 and 2 (SGLT-1 and SGLT-2).

Inn NameSotagliflozin
Usan NameSotagliflozin
Lab CodesLP-802034, LX-4211, SAR-439954
Chemical NameMethyl (5S)-5-C-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-1-thio-β-L-xylopyranoside
Chemical StructureSotagliflozin.png
Molecular FormulaC21H25ClO5S
Cas Registry Number1018899-04-1
New Molecular EntityYes
OriginatorLexicon Pharmaceuticals
DeveloperSanofi
Mechanism Of ActionSodium-glucose transporter 1 inhibitor, Sodium-glucose transporter 2 inhibitor
Who Atc CodesA05B-A (Liver therapy), A10X (Other Drugs Used in Diabetes)
Ephmra CodesA10X (Other Drugs Used in Diabetes), A5B (Hepatic Protectors, Lipotropics)
IndicationType 1 diabetes mellitus, Type 2 diabetes mellitus

Free counters!